QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Want to bring your treatment to the Finnish market? Then you need to understand what PALKO is and what it does.
In Finland, market access for hospital drugs and medical technologies isn’t just about regulatory approval, it’s about PALKO.
The Finnish Council for Choices in Health Care (Palveluvalikoimaneuvosto, PALKO) acts as a critical gatekeeper in the publicly funded healthcare system. Before a new inpatient pharmaceutical or health technology can be reimbursed or widely adopted, it must pass through PALKO’s recommendation and the associated […]
We´re back from the Ispe annual!
Thank you to everyone who made this year’s ISPE such a rewarding event.
Highlights from the Quantify team:
🧠 Emilie and Kirk’s session on extending inference from randomised clinical trials (RCTs) to the real world showcased several approaches in external control arms (ECA) and transportability analyses. We were excited to share real examples of both. Bridging RCTs with real-world data (RWD) is critically important to enable regulatory, payor, and clinical relevance.
🧠 […]
Great presentations and engaging debate sessions at the ISPE Annual Meeting yesterday!
Our colleagues Kirk Geale, PhD and Emilie Toresson Grip are still on site in Washington.
👉Don’t miss your chance to connect! Book a meeting to say hello before the conference wraps up.
We´re excited to welcome Zoë Morris as our new Research Analyst at Quantify Research!
🧠 Zoë obtained her bachelor’s degree in neuroscience from Cardiff University / Prifysgol Caerdydd and master’s degree in neuroimaging from UCL, followed by a master’s degree in public health from Karolinska Institutet. She brings experience in healthcare quality improvement and public health research, including with the […]